Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial

Lunedì 10 aprile 2023 circa 1 minuti di lettura

Journal and Affiliations:

JACC Cardiovascular Interventions, 10 aprile 2023

Antonio Landi, Cardiocentro Ticino, EOC, USI, Lugano

Enrico Frigoli, Cardiocentro Ticino, EOC, USI, Lugano

Marco Valgimigli, Cardiocentro Ticino, EOC, USI, Lugano e Facoltà di Scienze biomediche, USI, Lugano

Tags:
antiplatelet therapy
dual antiplatelet therapy
high bleeding risk
percutaneous coronary intervention
 
Authors:
Antonio Landi
Enrico Frigoli
Marco Valgimigli
Link: https://www.sciencedirect.com/science/article/abs/pii/S1936879823004156?via%3Dihub